Promakhos Therapeutics
Skip to content
Promakhos Therapeutics

Pagliuca Harvard Life Lab

Promakhos Therapeutics

Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.

Founders

Katerina Chatzi

Harvard Kenneth C. Griffin Graduate School of Arts & Sciences, Harvard Medical School

Jasper Neggers

Harvard Medical School

About Promakhos Therapeutics

School

Harvard Kenneth C. Griffin Graduate School of Arts & Sciences, Harvard Medical School

Connect

Email, Website, LinkedIn

Promakhos Therapeutics is developing cures for autoimmune diseases. Millions of people suffer from autoimmunity, yet there is currently no cure. Existing treatments focus on blocking the immune system to manage symptoms, often providing temporary relief. In contrast, Promakhos addresses the root cause of the problem. We aspire to deliver curative therapies by developing treatments inspired by the body's resident bacteria. These treatments aim to modulate humans’ innate ability to resolve inflammation and promote healing.

Join The Life Lab

The Life Lab is proud to support high-potential biotech and life-science ventures led by a Harvard affiliate.

A person on the phone inside the Life Lab office
Outside the Life Lab at night
Edit